`RESEARCH
`
`
`APPLICATION NUMBER:
`
`
`214120Orig1s000
`
`
`OFFICER/EMPLOYEE LIST
`
`
`
`MEMORANDUM
`
`DEPARTMENT OF HEALTH AND HUMAN SERVICES
`PUBLIC HEALTH SERVICE
`FOOD AND DRUG ADMINISTRATION
`CENTER FOR DRUG EVALUATION AND RESEARCH
`
`DATE:
`
`August 24, 2020
`
`TO:
`
`FROM:
`
`Administrative file for NDA 214120
`
`Rachel McMullen, MPH, MHA, Senior Regulatory Health Project Manager
`Division of Hematologic Malignancies I, Office of Oncologic Diseases
`
`SUBJECT: Officer/Employee List for NDA 214120
`
`APPLICATION/DRUG:
`
`NDA 214120, ONUREG, azacitidine, capsules
`
`The following officers or employees of FDA participated in the decision to approve this
`application and consented to be identified on this list:
`
`Baird, Amy
`Banerjee, Anamitro
`Conklin, Rachael
`Gehrke, Brenda
`Haider, Rabiya
`Jen, Emily
`Ju, Jing (Julia)
`Kang, Min
`Lee, Shwu Luan
`Leong, Ruby
`Lu, Min
`Marur, Shanthi
`McLamore, Sherita
`McMullen, Rachel
`Mehta, Hina
`Ni, Nina
`Przepiorka, Donna
`Redwood, Susan
`Shord, Stacy
`Swain, Richard
`Vallejo, Jonathon
`Vora, Neil
`Wang, Xin
`
`
`
`Reference ID: 4664402Reference ID: 4666382
`
`
`
`Signature Page 1 of 1
`--------------------------------------------------------------------------------------------
`This is a representation of an electronic record that was signed
`electronically. Following this are manifestations of any and all
`electronic signatures for this electronic record.
`--------------------------------------------------------------------------------------------
`/s/
`------------------------------------------------------------
`
`RACHEL S MCMULLEN
`08/31/2020 04:12:29 PM
`
`
`
`Reference ID: 4664402Reference ID: 4666382
`
`(
`
`
`
`